Tuesday brought a fresh batch of analyst initiations across several sectors, with Wall Street firms staking their claims on companies ranging from medical technology to energy services. Here's what the analysts are saying as they start their coverage.
Lumentum Gets the Biggest Vote of Confidence
Mizuho analyst Vijay Rakesh kicked off coverage of Lumentum Holdings Inc (LITE) with an Outperform rating and a $290 price target. That's a pretty optimistic call considering the optical components maker closed Monday at $242.07, meaning Rakesh sees about 20% upside ahead. Lumentum manufactures optical and photonic products for communications and commercial laser applications.
Medical Technology Catches Analyst's Eye
BTIG analyst Marie Thibault launched coverage on Kestra Medical Technologies Ltd (KMTS) with a Buy rating and a $32 price target. The medical device company finished Monday's session at $25.10, so Thibault is calling for roughly 28% gains from here. That's the kind of price target that gets investors' attention.
Specialty Chemicals Get the Nod
Freedom Capital Markets analyst David Silver started covering Innospec Inc (IOSP) with a Buy rating and set a price target of $93. Innospec, which makes specialty chemicals for fuel, personal care, and other applications, closed at $72.23 on Monday. Silver's target implies about 29% upside potential.
Healthcare REIT Draws Neutral Stance
Not every initiation was bullish. UBS analyst Michael Goldsmith began coverage of Sabra Health Care REIT Inc (SBRA) with a Neutral rating and a $20 price target. The healthcare-focused real estate investment trust ended Monday at $18.59, so even the neutral call suggests some modest appreciation ahead.
Energy Services Round Out the List
William Blair analyst Neal Dingmann initiated coverage on Kodiak Gas Services Inc (KGS) with an Outperform rating. The firm didn't announce a specific price target, but the Outperform rating indicates Dingmann expects the stock to beat the broader market. Kodiak Gas Services closed Monday's trading at $32.95.
These coverage initiations give investors fresh perspectives on companies that may have been flying under the radar. When analysts begin coverage, they're essentially telling the market these stocks are worth watching—and in most of these cases, worth buying.
